Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Laura Agnoletto"'
Autor:
Vera Damuzzo, Laura Agnoletto, Roberta Rampazzo, Francesca Cammalleri, Luca Cancanelli, Marco Chiumente, Stefano Costantino, Silvia Michielan, Federica Milani, Alessia Sartori, Melania Rivano, Daniele Mengato
Publikováno v:
Neurology International, Vol 13, Iss 4, Pp 682-694 (2021)
Health-related quality of life is frequently included in patient-reported outcomes aimed at evaluating the effectiveness of disease-modifying drugs for multiple sclerosis, but recent data about Italian patients are missing. A multicenter observationa
Externí odkaz:
https://doaj.org/article/9a7b6c9a184a43e7a57b929803249ede
Autor:
Vera Damuzzo, Laura Agnoletto, Luca Leonardi, Marco Chiumente, Daniele Mengato, Andrea Messori
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Some anti-cancer treatments (e. g., immunotherapies) determine, on the long term, a durable survival in a small percentage of treated patients; in graphical terms, long-term survivors typically give rise to a plateau in the right tail of the survival
Externí odkaz:
https://doaj.org/article/d8989ac039fe413692ad228c2c1e9b45
Autor:
Stefano Costantino, Daniele Mengato, Luca Cancanelli, Melania Rivano, Francesca Cammalleri, Roberta Rampazzo, Silvia Michielan, Laura Agnoletto, Marco Chiumente, Alessia Sartori, Federica Milani, Vera Damuzzo
Publikováno v:
Neurology International
Neurology International; Volume 13; Issue 4; Pages: 682-694
Neurology International, Vol 13, Iss 65, Pp 682-694 (2021)
Neurology International; Volume 13; Issue 4; Pages: 682-694
Neurology International, Vol 13, Iss 65, Pp 682-694 (2021)
Health-related quality of life is frequently included in patient-reported outcomes aimed at evaluating the effectiveness of disease-modifying drugs for multiple sclerosis, but recent data about Italian patients are missing. A multicenter observationa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af573204cc8e174381538363ca3023c
http://europepmc.org/articles/PMC8706851
http://europepmc.org/articles/PMC8706851
Autor:
Massimiliano, Lanzafame, Andrea, Tessari, Laura, Agnoletto, Ilaria, Coledan, Irene, Adami, Filippo, Viviani, Carla, Destro
Publikováno v:
Recenti progressi in medicina. 113(3)
Riassunto. La pandemia da covid-19 ha comportato un incremento dell'uso degli antibiotici e dell'antibiotico-resistenza negli ospedali, sia negli Stati Uniti che in Europa, causando un aumento della morbilità e della mortalità nei pazienti ospedali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::06c0239fb09a2b0c304a961ee67ada7b
https://pubmed.ncbi.nlm.nih.gov/35315453
https://pubmed.ncbi.nlm.nih.gov/35315453
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Patient reported outcomes (PRO) are increasingly used to evaluate effectiveness of treatments for multiple sclerosis (MS) and they often include an evaluation of health related quality of life (QoL). In 2017, the Italian Soc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a28a9e7fd99f24420f2ff9990826197
https://doi.org/10.1136/ejhpharm-2020-eahpconf.376
https://doi.org/10.1136/ejhpharm-2020-eahpconf.376
Autor:
Luca Leonardi, Andrea Messori, Marco Chiumente, Laura Agnoletto, Daniele Mengato, Vera Damuzzo
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:490-491
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09de5e3197975b1a1111018239614a5a
https://doi.org/10.1016/j.clml.2020.02.007
https://doi.org/10.1016/j.clml.2020.02.007
Autor:
Marco Chiumente, Daniele Mengato, Luca Leonardi, Vera Damuzzo, Laura Agnoletto, Andrea Messori
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology, Vol 9 (2019)
Some anti-cancer treatments (e. g., immunotherapies) determine, on the long term, a durable survival in a small percentage of treated patients; in graphical terms, long-term survivors typically give rise to a plateau in the right tail of the survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7438ea304c30f8d5fc72635719e6998a
https://pubmed.ncbi.nlm.nih.gov/31231609
https://pubmed.ncbi.nlm.nih.gov/31231609
Autor:
Federica Milani, Marco Chiumente, Francesca Cammalleri, Luca Cancanelli, Silvia Michielan, Stefano Costantino, Laura Agnoletto, Alessia Sartori, Roberta Rampazzo, Vera Damuzzo, Daniele Mengato
Publikováno v:
European Journal of Hospital Pharmacy. 29:364-364
The path to become a hospital pharmacist in Europe differs from nation to nation. In Italy, attendance at the postgraduate School of Hospital Pharmacy (SHP) is mandatory to work in the National Health System. Recent research published by the National
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78df9b2e928ac77aafd6c74ae1d5b20d
https://doi.org/10.1136/ejhpharm-2021-002839
https://doi.org/10.1136/ejhpharm-2021-002839
Autor:
Manuela Angileri, Vera Damuzzo, Andrea Messori, Marco Chiumente, Sabrina Trippoli, Paolo Baldo, Daniele Mengato, Angelo Claudio Palozzo, Carolina Laudisio, Elisa Ferracane, Mario Cirino, M. Cecilia Giron, Laura Agnoletto, Laura Bartoli
Publikováno v:
European Journal of Hospital Pharmacy
In Italy, there are 19 regions and two autonomous provinces, and each of these 21 jurisdictions has local responsibility for health care. As regards the COVID-19 pandemic, these 21 jurisdictions have been classified into three classes of risk (mild,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d88f2b24b578cecf3777ff1442360a76
https://doi.org/10.1136/ejhpharm-2021-002692
https://doi.org/10.1136/ejhpharm-2021-002692
Publikováno v:
International journal of clinical pharmacology and therapeutics. 57(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c3257c58bb0d6ba4cc2fba69146fb00
https://pubmed.ncbi.nlm.nih.gov/30369396
https://pubmed.ncbi.nlm.nih.gov/30369396